Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Journal of Thoracic Oncology
Personen und Körperschaften: Hong, S., Ahn, H.J., Kim, K.H., Lee, S.S., Lee, Y.G., Yuh, Y.J., Cheon, P.I., Chae, Y.S., Jang, T.W., Kang, J.
In: Journal of Thoracic Oncology, 12, 2017, 11, S. S2135-S2136
Format: E-Article
Sprache: Englisch
veröffentlicht:
Elsevier BV
Schlagwörter:
Pulmonary and Respiratory Medicine
Oncology
author_facet Hong, S.
Ahn, H.J.
Kim, K.H.
Lee, S.S.
Lee, Y.G.
Yuh, Y.J.
Cheon, P.I.
Chae, Y.S.
Jang, T.W.
Kang, J.
Hong, S.
Ahn, H.J.
Kim, K.H.
Lee, S.S.
Lee, Y.G.
Yuh, Y.J.
Cheon, P.I.
Chae, Y.S.
Jang, T.W.
Kang, J.
author Hong, S.
Ahn, H.J.
Kim, K.H.
Lee, S.S.
Lee, Y.G.
Yuh, Y.J.
Cheon, P.I.
Chae, Y.S.
Jang, T.W.
Kang, J.
spellingShingle Hong, S.
Ahn, H.J.
Kim, K.H.
Lee, S.S.
Lee, Y.G.
Yuh, Y.J.
Cheon, P.I.
Chae, Y.S.
Jang, T.W.
Kang, J.
Journal of Thoracic Oncology
P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
Pulmonary and Respiratory Medicine
Oncology
author_sort hong, s.
spelling Hong, S. Ahn, H.J. Kim, K.H. Lee, S.S. Lee, Y.G. Yuh, Y.J. Cheon, P.I. Chae, Y.S. Jang, T.W. Kang, J. 1556-0864 Elsevier BV Pulmonary and Respiratory Medicine Oncology http://dx.doi.org/10.1016/j.jtho.2017.09.1273 P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology
doi_str_mv 10.1016/j.jtho.2017.09.1273
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLmp0aG8uMjAxNy4wOS4xMjcz
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLmp0aG8uMjAxNy4wOS4xMjcz
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Elsevier BV, 2017
imprint_str_mv Elsevier BV, 2017
issn 1556-0864
issn_str_mv 1556-0864
language English
mega_collection Elsevier BV (CrossRef)
match_str hong2017p203022impactofegfrmutationonclinicaloutcomeofnintedanibplusdocetaxelinpreviouslytreatednonsmallcelllungcancernsclc
publishDateSort 2017
publisher Elsevier BV
recordtype ai
record_format ai
series Journal of Thoracic Oncology
source_id 49
title P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_unstemmed P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_full P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_fullStr P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_full_unstemmed P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_short P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_sort p2.03-022 impact of egfr mutation on clinical outcome of nintedanib plus docetaxel in previously treated non- small cell lung cancer (nsclc)
topic Pulmonary and Respiratory Medicine
Oncology
url http://dx.doi.org/10.1016/j.jtho.2017.09.1273
publishDate 2017
physical S2135-S2136
description
container_issue 11
container_start_page 0
container_title Journal of Thoracic Oncology
container_volume 12
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792324485984026624
geogr_code not assigned
last_indexed 2024-03-01T11:50:26.221Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=P2.03-022+Impact+of+EGFR+Mutation+on+Clinical+Outcome+of+Nintedanib+plus+Docetaxel+in+Previously+Treated+Non-+Small+Cell+Lung+Cancer+%28NSCLC%29&rft.date=2017-11-01&genre=article&issn=1556-0864&volume=12&issue=11&pages=S2135-S2136&jtitle=Journal+of+Thoracic+Oncology&atitle=P2.03-022+Impact+of+EGFR+Mutation+on+Clinical+Outcome+of+Nintedanib+plus+Docetaxel+in+Previously+Treated+Non-+Small+Cell+Lung+Cancer+%28NSCLC%29&aulast=Kang&aufirst=J.&rft_id=info%3Adoi%2F10.1016%2Fj.jtho.2017.09.1273&rft.language%5B0%5D=eng
SOLR
_version_ 1792324485984026624
author Hong, S., Ahn, H.J., Kim, K.H., Lee, S.S., Lee, Y.G., Yuh, Y.J., Cheon, P.I., Chae, Y.S., Jang, T.W., Kang, J.
author_facet Hong, S., Ahn, H.J., Kim, K.H., Lee, S.S., Lee, Y.G., Yuh, Y.J., Cheon, P.I., Chae, Y.S., Jang, T.W., Kang, J., Hong, S., Ahn, H.J., Kim, K.H., Lee, S.S., Lee, Y.G., Yuh, Y.J., Cheon, P.I., Chae, Y.S., Jang, T.W., Kang, J.
author_sort hong, s.
container_issue 11
container_start_page 0
container_title Journal of Thoracic Oncology
container_volume 12
description
doi_str_mv 10.1016/j.jtho.2017.09.1273
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLmp0aG8uMjAxNy4wOS4xMjcz
imprint Elsevier BV, 2017
imprint_str_mv Elsevier BV, 2017
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 1556-0864
issn_str_mv 1556-0864
language English
last_indexed 2024-03-01T11:50:26.221Z
match_str hong2017p203022impactofegfrmutationonclinicaloutcomeofnintedanibplusdocetaxelinpreviouslytreatednonsmallcelllungcancernsclc
mega_collection Elsevier BV (CrossRef)
physical S2135-S2136
publishDate 2017
publishDateSort 2017
publisher Elsevier BV
record_format ai
recordtype ai
series Journal of Thoracic Oncology
source_id 49
spelling Hong, S. Ahn, H.J. Kim, K.H. Lee, S.S. Lee, Y.G. Yuh, Y.J. Cheon, P.I. Chae, Y.S. Jang, T.W. Kang, J. 1556-0864 Elsevier BV Pulmonary and Respiratory Medicine Oncology http://dx.doi.org/10.1016/j.jtho.2017.09.1273 P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology
spellingShingle Hong, S., Ahn, H.J., Kim, K.H., Lee, S.S., Lee, Y.G., Yuh, Y.J., Cheon, P.I., Chae, Y.S., Jang, T.W., Kang, J., Journal of Thoracic Oncology, P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC), Pulmonary and Respiratory Medicine, Oncology
title P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_full P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_fullStr P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_full_unstemmed P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_short P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
title_sort p2.03-022 impact of egfr mutation on clinical outcome of nintedanib plus docetaxel in previously treated non- small cell lung cancer (nsclc)
title_unstemmed P2.03-022 Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
topic Pulmonary and Respiratory Medicine, Oncology
url http://dx.doi.org/10.1016/j.jtho.2017.09.1273